Insomnia and cognitive behavioural therapy—how to assess your patient and why it should be a standard part of care
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
". Disrupted sleep for any reason has immediate and long term consequences on physical and mental health. Insomnia disorder ("immoderate watchfulness") remains the commonest sleep disorder in primary and secondary care with an estimated 5-10% of the adult population affected. While it is commonly comorbid with other physical and mental health problems, the new diagnostic classification has been helpfully simplified such that it is considered a disorder in itself. If it is the patient's main concern, it warrants treatment. Patients and health professionals have often had limited teaching about effective strategies for insomnia which leaves many untreated and insomnia can be unfairly perceived as a challenging symptom to manage. The first line treatment is now well established as insomnia-specific cognitive behavioural therapy (CBTi) in the most recent US and European treatment guidelines. Over 25 years of high quality research have shown evidence for sustained improvements in sleep in those with insomnia alone or insomnia comorbid with other conditions. This is a simple CBT to deliver with better and safer outcomes than prescription hypnotics. Therefore, this review will cover the initial assessment of insomnia, including insomnia mimics, the selection of patients for treatment and the key components of CBT therapy. Finally, the review will cover evidence for different modes of delivery (online, self, help, group or individual face to face) in a variety of clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of insomnia: what we know and what we still need to learn
Ohayon, M. M. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0186 · Cited by 3,743 · cited 1×
“Insomnia disorder remains the commonest sleep disorder in primary care with multiple cohort studies estimating at least 5–10% of the population affected (7-9).”
BackgroundOhayon, M. M., Carskadon, M. A., Guilleminault, C., & Vitiello, M. V. (2004) · Sleep · doi:10.1093/sleep/27.7.1255 · Cited by 3,349
Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.01.011 · Cited by 2,779
International Classification of Sleep Disorders
Thorpy, M. (2017) · Sleep Disorders Medicine · doi:10.1007/978-1-4939-6578-6_27 · Cited by 2,505
European guideline for the diagnosis and treatment of insomnia
Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., Espie, C. A., Garcia‐Borreguero, D., Gjerstad, M., Gonçalves, M., et al. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12594 · Cited by 2,049 · cited 1×
“The latest guidelines from the European Sleep Research Society and the American Academy of Sleep Medicine have all performed systematic reviews of relevant meta-analyses and concluded that CBTi should be the first line therapy offered to patients (30,31).”
BackgroundQaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965 · cited 2×
“Sedating antidepressants have very weak evidence for benefit and tolerance develops quickly, as it does for antihistamines which are not recommended in any of the current guidelines for chronic insomnia (31).”
BackgroundThe effects of physical activity on sleep: A meta-analytic review
Kredlow, M. A., Capozzoli, M. C., Hearon, B. A., Calkins, A. W., & Otto, M. W. (2015) · Journal of Behavioral Medicine · doi:10.1007/s10865-015-9617-6 · Cited by 1,333
A behavioral perspective on insomnia treatment
Spielman, A. J., Caruso, L. S., & Glovinsky, P. B. (1987) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30532-x · Cited by 1,261
MORIN, C., LEBLANC, M., DALEY, M., GREGOIRE, J., & MERETTE, C. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.08.008 · Cited by 1,191 · cited 1×
“Insomnia disorder remains the commonest sleep disorder in primary care with multiple cohort studies estimating at least 5–10% of the population affected (7-9).”
BackgroundSedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161
Sleep, circadian rhythms, and delayed phase in adolescence
Crowley, S. J., Acebo, C., & Carskadon, M. A. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.12.002 · Cited by 1,127 · cited 1×
“Teenagers and young adults need 8–9 hours of sleep on average with a delay in sleep phase such that many fall asleep after rather than before midnight (3).”
BackgroundBehavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999) · JAMA · doi:10.1001/jama.281.11.991 · Cited by 1,095
Prevalence of healthy sleep duration among adults – United States, 2014
Liu, Y., Wheaton, A. G., Chapman, D. P., Cunningham, T. J., Lu, H., & Croft, J. B. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6506a1 · Cited by 914
Zachariae, R., Lyby, M. S., Ritterband, L. M., & O'Toole, M. S. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.10.004 · Cited by 704 · cited 15×
“In reality, hypnotic prescribing remains common in the UK and elsewhere because of a lack of knowledge of CBTi as an available therapy and because many patients essentially present in crisis or with acute distress, despite a chronic problem.”
BackgroundInfluentialEspie, C. A., Broomfield, N. M., MacMahon, K. M. A., Macphee, L. M., & Taylor, L. M. (2006) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.03.002 · Cited by 532
Sleep changes in the disorder of insomnia: a meta-analysis of polysomnographic studies
Baglioni, C., Regen, W., Teghen, A., Spiegelhalder, K., Feige, B., Nissen, C., & Riemann, D. (2014) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2013.04.001 · Cited by 386 · cited 2×
“Hyperarousal develops such that those with insomnia have a fragmented nocturnal electroencephalogram (EEG) with microarousals, increased heart rate and blood pressure relative to normal sleepers (17).”
BackgroundCognitive Behavioral Therapy in Persons with Comorbid Insomnia: A Meta-Analysis
Geiger-Brown, J. M., Rogers, V. E., Liu, W., Ludeman, E. M., Downton, K. D., & Diaz-Abad, M. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.11.007 · Cited by 331 · cited 1×
“A wide variety of co-morbid conditions were assessed with a recent large meta-analysis (34) and showed continued large effect sizes for the insomnia with modest benefits on the co-morbid conditions including chronic pain and depression.”
BackgroundMantua, J., Gravel, N., & Spencer, R. (2016) · Sensors · doi:10.3390/s16050646 · Cited by 314
Computerised Cognitive Behavioural Therapy for Insomnia: A Systematic Review and Meta-Analysis
Cheng, S. K., & Dizon, J. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000335379 · Cited by 241 · cited 2×
“The most recent meta-analyses of computerised CBTi show similar benefit to face to face CBTi (38), There were smaller effect sizes in an earlier meta-analysis published in 2012 (39).”
BackgroundInsomnia and comorbid psychiatric disorders
Riemann, D. (2007) · Sleep Medicine · doi:10.1016/s1389-9457(08)70004-2 · Cited by 198 · cited 1×
“It is more common in women and it is commonly comorbid with other mental and physical health problems (12).”
BackgroundThe evidence base of sleep restriction therapy for treating insomnia disorder
Miller, C. B., Espie, C. A., Epstein, D. R., Friedman, L., Morin, C. M., Pigeon, W. R., Spielman, A. J., & Kyle, S. D. (2014) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.01.006 · Cited by 192
Ellis, J. G., Cushing, T., & Germain, A. (2015) · SLEEP · doi:10.5665/sleep.4752 · Cited by 130
Shiftwork and sickness absence among police officers: the BCOPS study
Fekedulegn, D., Burchfiel, C. M., Hartley, T. A., Andrew, M. E., Charles, L. E., Tinney-Zara, C. A., & Violanti, J. M. (2013) · Chronobiology International · doi:10.3109/07420528.2013.790043 · Cited by 73
Co-occurring insomnia and obstructive sleep apnea
Lichstein, K. L., Justin Thomas, S., Woosley, J. A., & Geyer, J. D. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2013.02.008 · Cited by 55
Cited by
Sleep and the athlete: narrative review and 2021 expert consensus recommendations
Walsh, N. P., Halson, S. L., Sargent, C., Roach, G. D., Nédélec, M., Gupta, L., Leeder, J., Fullagar, H. H., Coutts, A. J., Edwards, B. J., et al. (2021) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-102025 · Cited by 571
Selvanathan, J., Pham, C., Nagappa, M., Peng, P. W. H., Englesakis, M., Espie, C. A., Morin, C. M., & Chung, F. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101460 · Cited by 206
The role of the circadian system in the etiology and pathophysiology of ADHD: time to redefine ADHD?
Bijlenga, D., Vollebregt, M. A., Kooij, J. J. S., & Arns, M. (2019) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-018-0271-z · Cited by 137
“Moreover, it is safe, has no side effects, and is therefore preferred over sleep medication (Anderson 2018).”
BackgroundAlshehri, M. M., Alothman, S. A., Alenazi, A. M., Rucker, J. L., Phadnis, M. A., Miles, J. M., Siengsukon, C. F., & Kluding, P. M. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00612-6 · Cited by 41
Ruan, J., Chen, S., Liang, J., Mak, Y. W., Yee Ho, F. Y., Chung, K. F., Kwun Tong, A. K., Zhang, X. L., & Yeung, W. F. (2022) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2022.09.002 · Cited by 20
Metadata
- Authors
- Anderson, K. N.
- Venue
- Journal of Thoracic Disease
- Publisher
- AME Publishing Company
- Published
- 2018-01
- Volume
- 10
- Issue
- S1
- Pages
- S94-S102
- ISSN
- 2072-1439 (ISSN-L)
- 2077-6624
- OpenAlex
- W2786063199
- Cited by
- 53
- References
- 24
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.